-
公开(公告)号:US20230212613A1
公开(公告)日:2023-07-06
申请号:US17996733
申请日:2021-05-06
申请人: CELLECTIS S.A.
IPC分类号: C12N15/90 , C07K14/725 , C12N9/22 , C12N5/0783
CPC分类号: C12N15/907 , C07K14/7051 , C12N9/22 , C12N5/0636 , C12N2310/20
摘要: The present disclosure provides methods for targeted insertion of an exogenous sequence at a genomic locus in a cell, wherein said insertion is induced by a sequence-specific endonuclease that has cleavage activity at said locus, at least 5 hours before the introduction into said cell of a DNA template comprising said exogenous sequence.
-
公开(公告)号:US20230279440A1
公开(公告)日:2023-09-07
申请号:US17996701
申请日:2021-05-06
申请人: CELLECTIS S.A.
发明人: Alexandre JUILLERAT , Philippe DUCHATEAU , Patrick HONG , Laurent POIROT , Brian BUSSER , Alex BOYNE
CPC分类号: C12N15/907 , C12N15/86 , C12N2750/14143 , C12N2830/42
摘要: The present disclosure provides methods to genetically modify cells by insertion of an artificial exon (ArtEx) for delivery of therapeutic proteins in specific cell types and more particularly engineered cells for expression of a transgene into the brain of a patient.
-